Parametric Portfolio Associates’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $784K | Buy |
45,497
+20,364
| +81% | +$351K | ﹤0.01% | 2891 |
|
|
2021
Q4 | $365K | Buy |
25,133
+5,360
| +27% | +$77.8K | ﹤0.01% | 3203 |
|
|
2021
Q3 | $356K | Buy |
+19,773
| New | +$356K | ﹤0.01% | 3233 |
|
|
2021
Q2 | – | Sell |
-84,276
| Closed | -$2.12M | – | 3555 |
|
|
2021
Q1 | $2.12M | Buy |
+84,276
| New | +$2.12M | ﹤0.01% | 2741 |
|
|
2020
Q2 | – | Sell |
-18,418
| Closed | -$19K | – | 3909 |
|
|
2020
Q1 | $19K | Sell |
18,418
-112,147
| -86% | -$116K | ﹤0.01% | 3895 |
|
|
2019
Q4 | $247K | Buy |
130,565
+105,349
| +418% | +$199K | ﹤0.01% | 3660 |
|
|
2019
Q3 | $27K | Sell |
25,216
-65,651
| -72% | -$70.3K | ﹤0.01% | 3922 |
|
|
2019
Q2 | $199K | Buy |
90,867
+33,646
| +59% | +$73.7K | ﹤0.01% | 3740 |
|
|
2019
Q1 | $343K | Sell |
57,221
-39,201
| -41% | -$235K | ﹤0.01% | 3500 |
|
|
2018
Q4 | $713K | Sell |
96,422
-7,604
| -7% | -$56.2K | ﹤0.01% | 3155 |
|
|
2018
Q3 | $1.51M | Sell |
104,026
-7,339
| -7% | -$107K | ﹤0.01% | 2887 |
|
|
2018
Q2 | $2.22M | Buy |
111,365
+66,254
| +147% | +$1.32M | ﹤0.01% | 2614 |
|
|
2018
Q1 | $790K | Buy |
45,111
+20,077
| +80% | +$352K | ﹤0.01% | 3129 |
|
|
2017
Q4 | $617K | Buy |
25,034
+2,218
| +10% | +$54.7K | ﹤0.01% | 3235 |
|
|
2017
Q3 | $589K | Sell |
22,816
-5,427
| -19% | -$140K | ﹤0.01% | 3324 |
|
|
2017
Q2 | $766K | Sell |
28,243
-27,154
| -49% | -$736K | ﹤0.01% | 3127 |
|
|
2017
Q1 | $1.65M | Buy |
55,397
+22,223
| +67% | +$663K | ﹤0.01% | 2571 |
|
|
2016
Q4 | $900K | Buy |
+33,174
| New | +$900K | ﹤0.01% | 2897 |
|